| Breakdown | Dec 2025 | Dec 2024 | Jun 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 154.89B | 252.76B | 401.01B | 430.37B | 523.06B |
| Gross Profit | -43.12B | -1.69B | -93.61B | 32.88B | 92.78B |
| EBITDA | 20.30B | -15.90B | -159.67B | 7.63B | 63.74B |
| Net Income | 3.26B | -32.84B | -178.40B | -6.05B | 26.80B |
Balance Sheet | |||||
| Total Assets | 812.12B | 1.04T | 1.29T | 1.74T | 1.95T |
| Cash, Cash Equivalents and Short-Term Investments | 12.19B | 15.06B | 18.82B | 139.69B | 161.16B |
| Total Debt | 150.64B | 256.00B | 251.65B | 271.72B | 318.61B |
| Total Liabilities | 767.86B | 984.59B | 1.20T | 1.43T | 1.65T |
| Stockholders Equity | -859.00M | -7.18B | 25.95B | 203.62B | 198.74B |
Cash Flow | |||||
| Free Cash Flow | 1.53B | -3.32B | -77.06B | 33.68B | 7.26B |
| Operating Cash Flow | 1.53B | -3.28B | -76.13B | 35.62B | 10.86B |
| Investing Cash Flow | 1.65B | 6.05B | 9.54B | 4.41B | -18.04B |
| Financing Cash Flow | -3.73B | -3.53B | -54.44B | -58.69B | -12.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
51 Neutral | HK$18.78B | 21.90 | 1.53% | 2.46% | 0.69% | -16.87% | |
41 Neutral | HK$4.77B | -1.09 | -29.07% | ― | -42.63% | 23.39% | |
40 Underperform | HK$9.18B | -0.17 | -3.01% | ― | -38.67% | ― |